News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Dr. Peter Weiss, OBGYN, FACOG, Rodeo Drive Women’s Health Clinic

Advertisement

Articles by Dr. Peter Weiss, OBGYN, FACOG, Rodeo Drive Women’s Health Clinic

Mitigating Low Patient Awareness of Treatment Options for Abnormal Uterine Bleeding

ByDr. Peter Weiss, OBGYN, FACOG, Rodeo Drive Women’s Health Clinic
July 19th 2019
Advertisement

Latest Updated Articles

  • Mitigating Low Patient Awareness of Treatment Options for Abnormal Uterine Bleeding
    Mitigating Low Patient Awareness of Treatment Options for Abnormal Uterine Bleeding

    Published: July 19th 2019 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

DARE to PLAY sildenafil cream becomes commercially available for women in select states

2

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

3

High costs and transfusions linked to acute heavy menstrual bleeding

4

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

5

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us